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Alcoholism 
hypophosphatemia and renal tubular 
dysfunct ion, 100:502 
porta l perfusion after distal splenorenal 
shunt, 100:799-cr 
Alkaline phosphatase 
i n fu lminant Wilsonian hepatitis, 100: 
1129 
i n pr imary sclerosing cholangitis, 100: 
1710 
w i t h ulcerative colit is , 100:1319 
Aluminum b i n d i n g to gastric ulcer sites 
(rabbit), 100:1201 
American Gastroenterological Associa-
tion, five-year plan, 100:301 
Amino acid 
consumption test, thyro id role i n exo-
crine pancreatic funct ion , 100:1392 
pancreatic uptake, effect of pancreatic 
polypeptide, thyrotropin-releasing 
hormone, and glucagon, 100:1095 
transport, i n brush border membrane 
vesicles, 100:1644 
Amylase, i n pancreatic duct obstruction 
(rat), 100:196 
Anal sphincter 
d u r i n g fasting, feeding, and sleep, 100: 
1016 
galanin effects, structure-activity rela-
t ionship (opossum), 100:711 
hereditary myopathy, w i t h proctalgia 
fugax and constipation, 100:805-cr 
i n myotonic muscular dystrophy, 100: 
424 
Anaphylaxis, intestinal f l u i d secretion, 
i n h i b i t i o n by diphenhydramine and 
indomethacin (rat), 100:922 
c t t - c l i n i c a l trends and topics 
e-editorial 
hs-his tor ica l series 
pa-progress article 
ra -review article 
ss-selected summary 
Anatomy, microvascular, of stomach (dog), 
100:638 
Anemia, pernicious, Helicobacter pylori 
infect ion, 100:328 
Aneurysm, extrahepatic portal vein, 100: 
818-cr 
Angiotensin-Converting enzyme, i n stom-
ach membranes (rabbit), 100:25 
Anorectum, sensory and motor funct ion , 
i n neurogenic fecal incontinence, 
100:465 
Anorexia, and a l b u m i n synthesis i n tumor-
bearing mice, 100:938 
Antibiotics, short-course vs. long-course 
treatment, of bacterial peritonitis, 
100:1737 
Antibodies 
ant i -neutrophi l cytoplasmic, i n ulcer-
ative coli t is , 100:1385, 1469-e, 1590 
h u m a n intestine maturation as nude 
mouse xenograft, 100:89 
monoclonal 
to bromodeoxyuridine, and hepatic 
regeneration (rabbit), 100:1135 
against CD18 leukocyte adhesion mol -
ecule, and indomethacin-induced 
gastric damage (rabbit), 100:878 
See also: Autoantibodies 
Antigens 
carbohydrate, i n pancreas, 100:1691 
class I I , i n intestinal epithelial cells i n 
inf lammatory bowel disease, 100:3, 
274-e 
e, hepatitis B virus mutants, and f u l m i -
nant hepatitis B, 100:1087, 1138-e 
hepatitis B surface, after renal transplan-
tation, 100:1432-cr 
Antiplasmin therapy i n intestinal l y m -
phangiectasia, 100:1152-c 
Arthritis, NSAID use, and Helicobacter 
pylori infections, 100:1653 
Ascites 
and bacterial peritonit is , antibiotic treat-
ments, 100:1737 
w i t h cirrhosis 
and bacterial peritonit is , animal model 
(rat), 100:489 
energy metabolism i n , 100:738 
vasopressin receptor blockade and ar-
terial pressure (rat), 100:494 
high-protein, i n AIDS, 100:745 
serum-ascites a lbumin concentration 
gradient, 100.1484-c 
Aspirin, and gastric mucosal damage, ag-
ing effects, 100:1626 
Atropine and loxiglumide, CCK i n h i b i t i o n 
i n regulation of pancreatic secretion, 
100:537 
Autoantibodies, enteric neuronal, i n pseu-
doobstruction w i t h small-cell lung 
carcinoma, 100:137 
Autoimmunity, pr imary bi l iary cirrhosis, 
100:822 
Autoradiography, substance P receptors i n 
gastrointestinal tract (cat), 100:1576 
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Bacteria 
colonic, and volatile metabolites, 100: 
1597 
peritonitis, antibiotic treatment courses, 
100:1737 
spiral, gastric infection (monkey), 100: 
884 
Balloons 
iatrogenic rupture of stomach, 100: 
1157-c 
intragastric, i n obesity, 100:847-c 
Behavior, mental stress, and cor t i cotropin-
releasing factor i n colonic m o t i l i t y 
(rat), 100:964 
Bicarbonate 
duodenal secretion, aging effects, 100: 
1471-ss 
and prostaglandin E 2, protect ion against 
acid-induced electrical conductance 
i n duodenum (guinea pig) , 100:648 
Bile 
choledochoduodenal f low, quanti tat ive 
cholescintigraphy of, 100:1106 
gallbladder, protein role i n format ion of 
cholesterol gallstones, 100:1724 
Bile acids 
conjugated, kinetics and molecular spec-
if ic i ty of absorption (rat), 100:212 
first-pass ileal clearance, 100:1100 
glucagon effects, i n l iver cirrhosis , 100: 
1671 
hepatic secretion, after chronic bi le 
drainage (rat), 100:1054 
tr ihydroxy, toxici ty of, 100:283-ss 
Bile duct 
epithel ium, and hepatocytes, o r ig in of, 
100:582-c 
extrahepatic cancer, endosonographic 
staging of, 100:1351 
stones, pulsed dye laser l i thot r ipsy , 100: 
1730 
Bile pigments, i n Crigler-Najjar disease, 
types 1 and 2, 100:783 
Bile salts, and cholestasis and hepatocellu-
lar necrosis, protection by ursodeox-
ycholate conjugates (rat), 100:203 
Biliary tract 
ampullary hamartoma, 100:795-cr 
and CCK receptor blockade, 100:1683 
cholesterol effects of oral and transder-
mal estradiol, 100:482 
cirrhosis, bromodeoxyuridine uptake by 
hepatocytes, 100:725 
physicochemical determinants of shock-
wave l i thotr ipsy, 100:222 
primary cirrhosis, model auto immune 
disease, 100:822 
Textbook of Liver and Biliary Surgery, 
100:1478-br 
zonal heterogeneity and cell po lar i ty i n 
l iver after bile 
drainage (rat), 100:1054 
F. ;lirubin excretion, i n Crigler-Najjar dis-
ease, 100:783 
Biological index, alcoholic l iver disease i n 
drinkers, 100:1397 
Biopsy 
cancer surveillance i n ulcerative colitis , 
100:1241 
Diagnostic Pathology of the Intestinal Mu-
cosa: An Atlas and Review of Biopsy 
Interpretation, 100:1150-br 
Bleeding 
esophageal varices, portal pressure mon-
itoring, 100:1403 
variceal, prophylaxis for, 100:1778-ss 
Blood flow 
and adaptive cytoprotection of gastric 
mucosa (cat), 100:1249 
to gastric ulcers, indomethacin effect 
(rat), 100:1259 
hepatic, reciprocity not proven, 100: 
1483-c 
hepatofugal portal , i n liver cirrhosis, 
100:160 
portal perfusion after distal splenorenal 
shunt, i n alcoholism, 100:799-cr 
Blood pressure 
continuous monitor ing, bleeding esoph-
ageal varices, 100:1403 
vasopressin effects, dur ing hemorrhage 
dur ing esophageal varices, 100:1411 
Bombesin 
and Helicobacter pylori-associated gas-
t r i n release i n duodenal ulcers, 100: 
1571 
muscle contraction i n stomach and co-
lon (rabbit), 100:980 
Book Reviews 
Clinical Investigation of Gastric Function 
(volume 17 i n Frontiers of Gas-
trointestinal Research series), 100: 
1478 
Diagnostic Pathology of the Intestinal Mu-
cosa: An Atlas and Review of Biopsy 
Interpretation, 100:1150 
Dietary Fiber Research ,100:1782 
Familial Adenomatous Polyposis, 100: 
286 
Flexible Sigmoidoscopy: Techniques and 
Utilization, 100:845 
xHepatology: A Textbook of Liver Dis-
ease, 100:1150 
Immunology and Immunopathology of 
the Liver and Gastrointestinal Tract, 
100:1478 
Irritable Bowel Syndrome: One Disease, 
Several or None?, 100:1151 
new titles, 100:287, 580, 846, 1151, 
1479, 1783 
Planning an Endoscopy Suite for Office 
and Hospital, 100:286 
Practical Gastrointestinal Endoscopy, 
Third Edition, 100:580 
Progress in Liver Diseases. Volume IX, 
100:846 
Textbook of Liver and Biliaiy Surgery, 
100:1478-br 
Therapeutic Gastrointestinal Endoscopy, 
100:1782 
Therapy of Inflammatory Bowel Disease: 
New Medical and Surgical Ap-
proaches, 100:580 
Tomorrow's Doctors—The Path to Suc-
cessful Practice in the 1990's, 100: 
845 
Treatment of Digestive Disease with Su-
cralfate, 100:1783 
Brainstem, vagal fiber location, i n gastric 
acid st imulat ion (rat), 100:627 
Bromodeoxyuridine 
monoclonal antibodies, and hepatic re-
generation (rabbit), 100:1135 
uptake by hepatocytes, i n primary bi l iary 
cirrhosis, 100:725 
Budd-Chiari syndrome 
pulsed Doppler ultrasound, 100:1324 
venous stents, 100:1435-cr 
Calcitonin gene-related peptide, i n esoph-
ageal Langerhans cells, 100:560 
Calcium 
absorption i n intestine, putrescine ef-
fects on v i tamin D action (chick), 
100:113 
channel i n gastric chief cells, ethanol 
effect on pepsinogen release (guinea 
pig), 100:17 
channels in smooth muscle, 100:1448-
srr 
hypercalcemia and pancreatic lithogene-
sis, 100:291-c 




ltase expression, 100:1266 
colon, and p53 oncogene, 100:842-ss 
extrahepatic bile duct, endosonographic 
staging of, 100:1351 
gastrointestinal, somatostatin receptor 
imaging, 100:1143-ss 
liver, mimicked by hepatobiliary 
cryptosporidiosis and cytomegalovi-
rus infection, 100:1743 
pancreas 
carbohydrate antigens, 100:1691 
patterns of growth and metastases 
(hamster), 100:529 
surveillance i n ulcerative colitis , 100: 
1241 
i n ulcerative colitis , 100:570-ss 
See also Neoplasia. 
Capsaicin, and ethanol damage, 100: 
1155-c 
Carbamylcholine, and ion transport i n dis-
tal colon (pig), 100:703 
Carbohydrate 
antigens, i n pancreas, 100:1691 
malabsorption, i n chi ldren w i t h HIV i n -
fection, 100:1296 
volatile metabolites, intestinal, 100:1597 
Carcinoids, enterochromaffin-like cell, af-
ter partial gastric corpectomy (rat), 
100:311 
Carcinoma 
hepatocellular, and hepatitis C virus, 
100:1145-ss 
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pancreas and gastric, stimulation by in-
terleukin-3 and granulocyte-macro-
phage colony-stimulating factor, 
100:1338 
small-cell lung, enteric neuronal au-
toantibodies in pseudoobstruction, 
100:137 
Case Reports 
Ampullary hamartoma: endoscopic diag-
nosis and treatment, 100:795 
Clinical application of ras gene mutation 
for diagnosis of pancreatic adeno-
carcinoma, 100:233 
Erythropoietic protoporphyria: Unusual 
skin and neurological problems after 
liver transplantation, 100:1753 
Expandable venous stents for treatment 
of the Budd-Chiari syndrome, 100: 
1435 
Extrahepatic portal vein aneurysm asso-
ciated with a tortuous portal vein, 
100:818 
Gastrointestinal motor dysfunction in 
acquired selective cholinergic dys-
autonomia associated with infec-
tious mononucleosis, 100:252 
Granulocytic sarcoma of the colon, 100: 
555 
Hepatobiliary cryptosporidiosis and cy-
tomegalovirus infection mimicking 
metastatic cancer to the liver, 100: 
1743 
Hereditary internal anal sphincter myop-
athy causing proctalgia fugax and 
constipation. A newly identified 
condition, 100:805 
Herpes simplex virus hepatitis in preg-
nancy, acyclovir treatment, 100:239 
Insulin resistance in noncirrhotic idio-
pathic portal hypertension, 100:235 
Intrahepatic cholestasis of pregnancy 
and acute fatty liver of pregnancy, 
100:1123 
Intrahepatic cholesterol stones: rationale 
for dissolution therapy, 100:228 
Liver failure occurring as a component of 
exertional heatstroke, 100:1442 
Microvillus inclusion disease. In vitro 
jejunal electrolyte transport, 100: 
811 
Neutrophil dysfunction in glycogen stor-
age disease lb: Association with 
Crohn's-like colitis, 100:549 
Nonsteroidal antiinflammatory drug-
induced colonic strictures: A case 
report, 100:1119 
Overt hepatic encephalopathy precipi-
tated by zinc deficiency, 100:1114 
Recurrent acute fatty liver of pregnancy 
associated with fatty-acid oxidation 
defect in offspring, 100:544 
Redevelopment of hepatitis B surface 
antigen after renal transplantation, 
100:1432 
Role of continued drinking in loss of por-
tal perfusion after distal splenorenal 
shunt, 100:799 
Ulcerative colitis in the autotransplanted 
neovagina, 100:1749 
Cations, metal, mucin role in absorption of 
(rat), 100:129 
Cefotaxime, short-course vs. long-course 
treatment, for bacterial peritonitis, 
100:1737 
Ceftriaxone, and gallbladder sludge, 100: 
1665, 1769-e 
Celiac disease, postheparin plasma di-
amine oxidase, 100:583-c 
Cells 
of Cajal 
colon innervation, 100:570-ss 
interstitial, in small intestine, 
100:1417 
Langerhans, of esophagus, calcitonin 
gene-related peptide, 100:560 
neoplastic colonic epithelial (rat), 100: 
692 
oxynticopeptic, in gastric mucosa, effect 
of luminal acid on pH (frog), 100: 
606 
proliferating epithelial, in digestive tract, 
immunohistochemical labeling, 100: 
259 
Cephalosporins, ceftriaxone-associated 
gallbladder sludge, 100:1665, 
1769-e 
Chemotherapy, and hepatitis B virus reac-
tivation, 100:182 
Cholangitis, primary sclerosing 
asymptomatic, 100:294-c 
natural history and prognostic variables, 
100:1710 
neutrophil cytoplasmic antibodies, 100: 
1385, 1469-e 
in ulcerative colitis, 100:1319 
Cholecystokinin (CCK) 
and cholinergic system, regulation of 
pancreatic secretion, 100:537 
and gallbladder contractions, 100:847-c 
intestinal, during food deprivation (rat), 
100:909 
octapeptide 
hypothalamic, and colonic motor re-
sponse to meal (rat), 100:441 
neuromodulation of intestinal electro-
lyte transport (guinea pig), 100:344 
receptor blockade, pancreatic and biliary 
function, 100:1683 
Cholera toxin, and Entamoeba histolytica 
secretogogues, in colon (rat), 100: 
986 
Cholescintigraphy, quantitative, chole-
dochoduodenal bile flow, 100:1106 
Cholestasis 
intrahepatic, and fatty liver, in preg-
nancy, 100:1123-cr 
ursodeoxycholate conjugate effects (rat), 
100:203 
Cholesterol 
biliary, effects of oral and transdermal 
estradiol, 100:482 
gallstones, and mucolytic agents, 100: 
581-c 
hepatic metabolism i n Crohn's disease, 
ileal resection, 100:1046 
intrahepatic stones, rationale for dissolu-
t ion therapy, 100:228-cr 




i n peptic ulcer disease, 100:584-c 
i n postoperative stress ulcers, after coro-
nary artery bypass graft surgery, 
100:1515 
Circadian rhythm, arterial ketone body 
ratio i n liver dysfunction, 100:1371 
Cirrhosis 
w i t h ascites 
and bacterial peritonitis , animal model 
(rat), 100:489 
energy metabolism i n , 100:738 
vasopressin receptor blockade and ar-
terial pressure (rat), 100:494 
bi l iary , model autoimmune disease, 100: 
822 
glucose and fat metabolism dur ing star-
vat ion , 100:731 
l iver. See Liver disease. 
and portal hypertension, i n adult Nie-
mann-Pick disease, 100:567 
p r i m a r y bi l iary, bromodeoxyuridine up-
take by hepatocytes, 100:725 
prophylaxis for variceal bleeding, 100: 
1778-ss 
variceal hemorrhage, predict ion of, 100: 
1332 
Clinical Challenges, Rapidly progressive 
l iver failure i n a 65-year-old woman, 
100:1462 
Clinical Studies 
adenocarcinoma of colon and rectum i n 
persons under 40, 100:1033 
adenovirus colitis i n AIDS, 100:976 
aging role i n aspirin-induced gastric m u -
cosal damage, 100:1626 
airway responsiveness to methacholine, 
i n irritable bowel syndrome, 100:68 
ambulatory esophageal combined p H / 
manometry, 100:1630 
anal m o t i l i t y dur ing fasting, feeding, and 
sleep, 100:1016 
anal sphincter i n myotonic muscular 
dystrophy, 100:424 
anorectal funct ion i n neurogenic fecal 
incontinence, i n mul t ip le sclerosis 
and diabetes mell i tus , 100:465 
ant i -neutrophi l cytoplasmic antibodies 
i n ulcerative colitis , 100:1590 
antroduodenal mot i l i t y , enprostil effects, 
100:59 
bromodeoxyuridine uptake by hepato-
cytes, i n primary bi l iary cirrhosis, 
100:725 
Budd-Chiar i syndrome diagnosis by 
pulsed Doppler ultrasound, 100: 
1324 
cancer surveillance i n ulcerative colitis, 
100:1241 
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CCK receptor blockade and pancreatic 
and bi l iary funct ion , 100:1683 
ceftriaxone-associated gallbladder 
sludge, 100:1665, 1769-e 
cholesterol gallstone formation, role of 
protein i n gallbladder bile, 100:1724 
cholinergic system and CCK i n regula-
t ion of pancreatic secretion, 100:537 
collagen propeptides as growth markers 
i n inflammatory bowel disease i n 
chi ldren, 100:971 
colonic glycoproteins i n monozygotic 
twins w i t h inflammatory bowel dis-
ease, 100:419 
Crigler-Najjar disease, types 1 and 2, bile 
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100:1616 
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body ratio i n liver disease, 100:1371 
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collection, 100:1362 
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bile duct cancer, 100:1351 
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sis, 100:738 
enteric neuronal autoantibodies i n 
small-cell lung carcinoma, 100:137 
esophageal emptying w i t h hiatal hernia, 
100:596 
esophageal pH-metry i n reflux laryngitis, 
100:305 
first-pass ileal clearance of bile acids, 
100:1100 
gallbladder morphology after gallstone 
dissolution w i t h methyl terf-butyl 
ether, 100:1718 
gallstone incidence, ultrasonographic 
study, 100:790 
gastroduodenal m o t i l i t y i n duodenal u l -
cer disease, 100:892 
glucagon effects on bile acids i n liver 
cirrhosis, 100:1671 
glucose and fat metabolism dur ing star-
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Helicobacter pylori infect ion i n perni-
cious anemia, 100:328 
hepatic metabolism of cholesterol, i n 
Crohn's disease, 100:1046 
hepatitis B virus reactivation, and cyto-
toxic therapy, 100:182 
hepatobiliary effects of oral and transder-
mal estradiol, 100:482 
high-protein ascites i n AIDS, 100:745 
H I V infection of enterocytes and mono-
nuclear cells i n je junum, 100:1521 
hypoechoic lesions i n fatty liver, 100: 
1678 
hypophosphatemia and renal tubular 
dysfunction in alcoholics, 100:502 
inflammatory bowel disease i n children 
of both parents w i t h disease, 100: 
1638 
injection or heat probe for bleeding u l -
cers, 100:33 
interferon alfa therapy i n hepatitis B v i -
rus infection, 100:756 
intestinal decontamination, and bacte-
r ia l peritonit is , 100:477 
lactase expression by vi l lous enterocytes, 
i n adult hypolactasia, 100:359 
laser therapy and intubat ion i n endo-
scopic pal l iat ion for malignant dys-
phagia, 100:1303 
leukocyte adhesion molecules i n inf lam-
matory bowel disease, expression by 
mucosal mononuclear phagocytes, 
100:150 
leukocyte adhesion molecules i n liver, i n 
hepatitis B virus infection, 100:749 
malnutr i t ion and carbohydrate malab-
sorption i n chi ldren w i t h H I V infec-
t ion , 100:1296 
melanosis of esophagus, 100:13 
mult i focal colitis and chronic diarrhea 
epidemic, 100:458 
neurohormonal factors i n funct ional 
dyspepsia, 100:1311 
neutrophi l cytoplasmic antibodies, i n 
primary sclerosing cholangitis and 
ulcerative colitis , 100:1385 
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dine or omeprazole, 100:873 
NSAID use and Helicobacterpylori.a in-
fections, 100:1653 
omeprazole for duodenal ulcer relapse, 
dosage comparison, 100:663 
omeprazole effects on gastric endocrine 
cells, i n duodenal ulcer patients, 
100:1563 
oral hyperalimentation in very short 
bowel syndrome, 100:1502 
orni thine decarboxylase and tyrosine 
kinase, i n rectal mucosa w i t h pol -
yps, 100:1528 
platelet-activating factor i n stool, i n 
pouch ileoanal anastomosis and 
pouchit is , 100:1509 
portacaval shunt vs. endoscopic sclero-
therapy for variceal hemorrhage, 
100:1078 
portal pressure moni tor ing of bleeding 
f rom esophageal varices, 100:1403 
postoperative stress ulcers after coronary 
artery bypass surgery, 100:1515 
primary sclerosing cholangitis, natural 
history and prognostic variables, 
100:1710 
primary sclerosing cholangitis and ulcer-
ative colitis , 100:1319 
psychological treatment for irritable 
bowel syndrome, 100:450 
pulmonary hypertension i n portal hyper-
tension, 100:520 
pulsed dye laser l i thotr ipsy of bile duct 
stones, 100:1730 
screening colonoscopy i n asymptomatic 
persons w i t h negative fecal occult 
blood tests, 100:64 
sex differences i n M a n n i n g criteria i n 
irritable bowel syndrome, 100:591 
shock-wave bi l iary l i thotr ipsy, physico-
chemical determinants of, 100:222 
spontaneous hepatofugal portal f low i n 
liver cirrhosis, 100:160 
sterol b ind ing by pancreatic elastase 1, 
100:768 
thromboxane A 2 and prostacyclin i n 
liver disease and hepatorenal syn-
drome, 100:1069 
thyro id role i n exocrine pancreatic func-
t ion , 100:1392 
variceal hemorrhage i n cirrhosis, 100: 
1332 
vasopressin effects on portal pressure on 
bleeding esophageal varices, 100: 
1411 
VIP and diarrhea, 100:99 
v i tamin A hepatotoxicity, 100:1701 
Wilson's disease and chronic active hep-
atitis, 100:762 
Colitis 
acute, colonic motor act ivity (dog), 100: 
954 
adenovirus, i n AIDS, 100:976 
Crohn's-like, and glycogen storage dis-
ease lb , neutrophi l dysfunct ion, 
100:549-cr 
inter leukin l ß expression by enterocytes 
(rat), 100:1180 
mult i focal , i n chronic diarrhea epidemic, 
100:458 
ulcerative 
ant i -neutrophi l cytoplasmic antibod-
ies, 100:1590 
in autotransplanted neovagina, 100: 
1749-cr 
cancer surveillance, 100:570-ss, 1241 
and primary sclerosing cholangitis, 
100:1319, 1469-e 
Collagen propeptides, growth markers i n 




in persons under 40, 100:1033 
sucrase-isomaltase expression, 100: 
1266 
bombesin-stimulated muscle contraction 
(rabbit), 100:980 
cancer, and p53 oncogene, 100:842-ss 
distal, innervation i n diabetes (rat), 100: 
1024 
Familial Adenomatous Polyposis,100: 
286-br 
glycoproteins, i n monozygotic twins 
w i t h inflammatory bowel disease, 
100:419 
granulocytic sarcoma, 100:555-cr 
hyperplastic polyps 
and adenomas, 100:1142-ss 
i n sigmoidoscopy as markers for prox i -
mal adenomas, 100:564 
innervation of cells of Cajal, 100:572-ss 
ion transport, neurotransmitter effects 
(pig), 100:703 
m o t i l i t y 
i n acute colitis (dog), 100:954 
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i n mental stress, release of corticotro-
pin-releasing factor (rat), 100:964 
motor response to meal, role of hypotha-
lamic CCK-8 (rat), 100:441 
mucosal mononuclear phagocytes, ex-
pression of leukocyte adhesion mol -
ecules, i n inf lammatory bowel dis-
ease, 100:150 
muscle contraction, anatomic correla-
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neoplastic epithelial cells (rat), 100:692 
secretagogue act ivity of Entamoeba his-
tolytica and cholera toxin (rat), 100: 
986 
strictures, NSAID-induced, 100:1119-cr 
tissues and nerves, tachykinin effects 
(cat), 100:431 
Colonoscopy screening, i n asymptomatic 
average-risk persons w i t h negative 
fecal occult blood tests, 100:64 
Computerized tomography 
intrahepatic cholesterol stones, 100: 
228-cr 
shock-wave bi l iary l i thotr ipsy, 100:222 
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cost effective treatment i n elderly, 100: 
1474-ss 
hereditary internal anal sphincter myop-
athy, 100:805-cr 
Contraction 
bombesin-stimulated, i n stomach and 
colon (rabbit), 100:980 
colonic muscle, anatomic correlations 
(rabbit), 100:75 
Correspondence 
Asymptomatic PSC—Do they really have 
progressive disease? 100:294 
Cholecystokinin-induced contractions i n 
the opossum gallbladder, 100:847 
Chronic alcohol ingestion and n u t r i t i o n , 
100:295 
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Reciprocity not proven i n hepatic blood 
f low, 100:1483 
Relation among personality and symp-
toms i n nonulcer dyspepsia and the 
irritable bowel syndrome, 100:1154 
Relationship between ulcer healing and 
acid suppression, 100:1482 
Retinopathy i n pancreatic diabetes, 100: 
585 
Serum l a m i n i n and N-terminal type I I I 
procollagen i n chronic alcoholic 
liver disease, 100:292 
Serum-ascites a lbumin concentration 
gradient (A-GRAD) i n the predict ion 
of portal hypertension i n ascitic pa-
tients, 100:1484 
Smoking habit enhanced pepsinogen 
group I i n healthy subjects, 100:288 
Transcellular transport of v i t a m i n B, 2 , 
100:291 
Type B gastritis, 100:290 
Use of 6-mercaptopurine i n adolescents, 
100:1156 
Corrosion casting, microvascular anatomy 
of stomach (dog), 100:638 
Corticotropin-releasing factor, and co-
lonic m o t i l i t y i n mental stress (rat), 
100:964 
Cost-effectiveness, of Cimetidine i n peptic 
ulcer disease, 100:584-c 
Coupling, intercellular, i n intestinal 
smooth muscle, 100:1776-ss 
Crigler-Najjar disease 
differential diagnosis of types 1 and 2, 
bile pigment analysis, 100:783 
and liver transplantation, 100:279-ss 
Crohn's disease 
granulomatous vasculitis i n , 100:1279 
hepatic metabolism of cholesterol, ileal 
resection, 100:1046 
pS2 and hSP genes as markers of ulcer-
ation, 100:375 
zinc and malnutr i t ion effect on i m m u n o -
logical functions, 100:1616 
Cyclic adenosine monophosphate, and 
ileal electrolyte transport (rabbit, 
rat), 100:410 
Cyclic nucleotides, and calcium channels 
i n smooth muscle, 100:1448-srr 
Cyclooxygenase, and anaphylaxis-evoked 
fluid secretion i n intestine (rat), 100: 
922 
Cystic fibrosis 
l iver dysfunct ion, bile acid treatment, 
100:1476-ss 
retrovirus-mediated gene transfer, 100: 
843 
ursodeoxycholic acid treatment, 100: 
841-ss 
Cytochrome P-450, omeprazole effects, 
100:1157-c, 1488-c 
Cytochrome P450IA2, i n liver, 100:1487-c 
Cytomegalovirus infection, and hepatobil-
iary cryptosporidiosis m i m i c k i n g 
liver cancer, 100:1743-cr 
Cytoprotection 
adaptive, blood flow role i n gastric m u -
cosa (cat), 100:1249 
surface-active phosphol ipid effect on 
gastric mucosa (Necturus), 100:38 
Cytotoxicity, free radical in jury of IEC-18 
small intestinal epithelial cells, 100: 
1533 
Development 
lactase expression i n je junum and i leum 
(rat), 100:388 
liver, Cu-Zn and M n superoxide dismu-
tases (rat), 100:1062 
Dexamethasone, and macrophage engulf-
ment of mucosal mast cells (rat), 
100:929 
Diabetes 
anorectal sensory and motor funct ion, 
100:465 
and cholinergic transmission i n i leum 
(rat), 100:123 
pancreatic, retinopathy i n , 100:585-c 
streptozotocin, innervation of i leum and 
distal colon (rat), 100:1024 
Diamine oxidase, postheparin, i n celiac 
disease, 100:583-c 
Diarrhea 
ant i -neutrophi l cytoplasmic antibodies, 
i n ulcerative colitis, 100:1590 
chronic, mult i focal colitis , 100:458 
i n ciguatera fish poisoning, 100:471 
jejunal electrolyte transport i n microvi l -
lus inc lus ion disease, 100:811-cr 
VIP screening, 100:99 
Diet 
Dietary Fiber Research, 100:1782-br 
fat, and gastric lipases (rabbit), 100:1582 
Dieting, and metabolic rate i n obesity, 100: 
1146-ss 
Diphenhydramine and indomethacin, i n -
h i b i t i o n of anaphylaxis-evoked f l u i d 
secretion (rat), 100:922 
DNA 
amplif icat ion method, hepatitis B virus 
genome sequencing, 100:175 
hepatitis B virus , interferon alfa effects, 
100:756 
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Dopamine receptors, gastric smooth mus-
cle (guinea pig), 100:1224 
Drug interactions, omeprazole and induc-
t ion of cytochrome P-450, 100: 
1157-c 
Duodenal ulcers. See Ulcers. 
Duodenum 
acid-induced electrical conductance, 
protection by bicarbonate and pros-
taglandin E 2 (guinea pig), 100:648 
mucosa, polyamines and ornithine de-
carboxylase after stress (rat), 100: 
333 
Dysautonomia, acquired selective chol in-
ergic, associated w i t h infectious 
mononucleosis, gastrointestinal mo-
tor dysfunction, 100:252-cr 
Dyspepsia 
neurohormonal factors, 100:1311 
nonulcer, personality assessment, 100: 
1154-c 
Dysphagia, malignant, comparison of laser 
therapy and intubat ion i n endo-
scopic pall iat ion, 100:1303 




sludge: What's i n a name? 100:1769 
Diagnosing an irritable bowel : does sex 
matter? 100:834 
Gastroenterology: 100 Volumes and go-
ing strong, 100:1773 
Hepatitis B virus unable to secrete e anti-
gen, 100:1138 
Major histocompatibi l i ty complex class 
I I expression on enterocytes: To 
present or not to present, 100:274 
Ulcerative colitis and sclerosing cholan-
gitis: Does 'IBD' mean ' Inflammed 
Bile Ducts'? 100:1469 
Electrocoagulation, BICAP and gold probe 
evaluation, 100:107 
Electrolyte transport 
i n distal colon, neurotransmitter effects 
(pig), 100:703 
ileal, p H and cyclic A M P effects (rabbit, 
rat), 100:410 
intestinal neuromodulation by CCK-8 
(guinea pig), 100:344 
in je junum, i n microvi l lus inclusion dis-
ease, 100:811-cr 
Electrophoresis, pancreatic secretory pro-
tein (rat), 100:775 
Electrophysiology 
acid-induced conductance i n duodenal 
mucosa, protection by bicarbonate 
and prostaglandin E2 (guinea pig), 
100:648 
calc ium channels i n smooth muscle, 
100:1448-srr 
calcium transport across duodenum and 
je junum (rat), 100:47 
gastric, and intestinal l ipids (cat), 100: 
380 
gastric protection by surface-active phos-
p h o l i p i d (Necturus), 100:38 
noncholinergic membrane potential re-
sponses, i n i leum (guinea pig), 100: 
1006 
sodium chloride absorption i n i l eum 
(rabbit), 100:403 
Encephalopathy, hepatic, and zinc defi-
ciency, 100:1114-cr 
Endoscopy 
of ampullary hamartoma, 100:795-cr 
bipolar electrocoagulation technique, 
evaluation of BICAP and gold 
probes, 100:107 
epinephrine injection, for bleeding u l -
cers, 100:33 
gallstone dissolution by ERCG, 100: 
1780-ss 
for malignant dysphagia, laser therapy 
and intubat ion, 100:1303 
melanosis of esophagus, 100:13 
for peptic ulcer hemorrhage, heater 
probe and alcohol injection, 100: 
575-ss 
Planning an Endoscopy Suite for Office 
and Hospital, 100:286-br 
Practical Gastrointestinal Endoscopy, 
Third Edition, 100:580-br 
sclerotherapy vs. portacaval shunt, for 
variceal hemorrhage, 100:1078 
spontaneous hepatofugal portal f low i n 
liver cirrhosis, 100:160 
Therapeutic Gastrointestinal Endoscopy, 
100:1782-br 
transpapillary drain , for disrupted pan-
creatic duct and peri pancreatic f l u i d 
collection, 100:1362 
Endosonographic staging of extrahepatic 
bile duct cancer, 100:1351 
Endotoxin, and intestinal mot i l i t y , role of 
free radicals and platelet-activating 
factor (rat), 100:946 
Energy metabolism 
i n ascites and liver cirrhosis, 100:738 
hepatic, and arterial ketone body ratio, 
glucagon effect (rabbit), 100:1041 
Enprostil, and antroduodenal mot i l i t y , 
100:59 
Entamoeba histolytica, secretagogue activ-
i ty i n colon (rat), 100:986 
Enteritis, rotavirus, glutamine s t imulat ion 
of jejunal sodium chloride absorp-
t ion (pig), 100:683 
Enterochromaffinlike-cell carcinoids, after 
gastric corpectomy (rat), 100:311 
Enterocytes 
inter leukin l ß expression, i n colitis (rat), 
100:1180 
jejunal, H I V infect ion, 100:1521 
Enteroscopy, for gastrointestinal bleeding, 
100:838-ss 
Environment, epidemiology of inf lamma-
tory bowel disease, 100:350 
Enzyme-linked immunosorbent assay 
(ELISA), epidemiology of Helicobac-
ter pylori infect ion, 100:1495 
Enzymes 
alkaline phosphatase, pr imary sclerosing 
cholangitis w i t h ulcerative col i t is , 
100:1319 
angiotensin-converting enzyme, i n stom-
ach membranes (rabbit), 100:25 
aspartate transaminase and alanine t ran-
saminase, i n fu lminant Wi lsonian 
hepatitis, 100:1129 
lactase, i n developing je junum and i l -
eum (rat), 100:388 
lipases, gastric, response to dietary fat 
(rabbit), 100:1582 
orni thine decarboxylase 
in duodenal mucosa after stress (rat), 
100:333 
and tyrosine kinase, rectal mucosa 
w i t h hyperplastic and adenomatous 
polyps, 100:1528 
2-oxo-acid dehydrogenases, i n pr imary 
bi l iary cirrhosis, 100:822 
oxygen metabolite-producing, and free 
radical in jury of small intestinal epi -
thelial cells, 100:1533 
and pancreatic duct obstruction (rat), 
100:196 
pancreatic 
elastase 1 , sterol-binding capacity, 
100:768 
i n frozen duodenal juice, 100:189 
sucrase-isomaltase, i n colon adenocarci-
nomas, 100:1266 
superoxide dismutase, Cu-Zn and M n , i n 
developing liver (rat), 100:1062 
Epidemiology 
adenocarcinoma of colon and rectum i n 
persons under 40, 100:1033 
of Helicobacter pylori, effect of age, race, 
and socioeconomic status, 100:1495 
of inflammatory bowel disease, 100:350 
mult i focal colitis and chronic diarrhea, 
100:458 
Epidermal growth factor and receptor, i n 
gastric carcinoma, 100:289-c 
Esophagus 
ambulatory combined pH/manometry, 
100:1630 
bleeding varices, portal pressure m o n i -
toring, 100:1403 
calc i tonin gene-related peptide i n 
Langerhans cells, 100:560 
emptying, and hiatal hernia, 100:598 
hypertrophic smooth muscle i n obstruc-
t ion (opossum), 100:853 
melanosis of, 100:13 
proximal pH-metry, i n reflux laryngit is , 
100:305 
varices, vasopressin effects on portal 
pressure dur ing hemorrhage, 100: 
1411 
Estrogen, oral and transdermal, hepatobil-
iary effects, 100:482 
Ethanol 
mucosal damage, capsaicin effect, 100: 
1155-c 
pepsinogen release, calcium channel i n 
gastric chief cells (guinea pig), 
100:17 
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secretory and metabolic effects in gastric 
mucosa (toad), 100:1288 
Famotidine, in postoperative stress ulcers, 
after coronary artery bypass graft 
surgery, 100:1515 
Fasting, and anal motility, 100:1016 
Fat 
dietary, and gastric lipase (rabbit), 100: 
1582 
metabolism during starvation in cirrho-
sis, 100:731 
Fatty acid oxidation defect in offspring, 
acute fatty liver of pregnancy, 100: 
544-cr 
Fatty liver, hypoechoic lesions, 100:1678 
Feces 
neurogenic incontinence, anorectal 
function in multiple sclerosis and 
diabetes mellitus, 100:465 
nutritional substrates and volatile me-
tabolites, 1597 
platelet-activating factor, in pouch ileoa-
nal anastomosis and pouchitis, 100: 
1509 
Feeding, and anal motility, 100:1016 
Feminization, portal-systemic shunting 
and hepatic sex hormone receptors 
(rat), 100:168 
Fiber, hydroxypropylmethylcellulose, and 
gastrointestinal transit and luminal 
viscosity (dog), 100:1217 
Filaments, in hypertrophic smooth muscle 
of esophageal obstruction (opos-
sum), 100:853 
Fish, ciguatera poisoning, diarrhea in , 
100:471 
Fluoroscopy, pulsed dye laser lithotripsy 
of bile duct stones, 100:1730 
Food 
deprivation, and intestinal C C K and so-
matostatin (rat), 100:909 
and hepatitis A , 100:577-ss 
Formycin B, sodium-dependent transport 
in intestinal epithelium (rabbit), 
100:1553 
Free radicals 
injury to IEC-18 small intestinal epithe-
lial cells, 100:1533 
and platelet-activating factor, in endot-
oxin effects on intestinal motility 
(rat), 100:946 
scavenging in inflammatory bowel dis-
ease, 100:581-c 
Freezer storage, and pancreatic enzymes, 
100:189 
G cells, secretory kinetics, omeprazole ef-
fects (rat), 100:1187 
G protein, and calcium channels in 
smooth muscle, 100:1448-srr 
Galanin 
in gastrointestinal tract, 100:1762-srr 
and internal anal sphincter, structure-
activity relationship (opossum), 100: 
711 
Gallbladder 
bile, protein role in formation of choles-
terol gallstones, 100:1724 
CCK-induced contractions (opossum), 
100:847-c 
after methyl terf-butyl ether dissolution 
of gallstones, 100:1718 




intrahepatic, dissolution therapy, 100: 
228-cr 
and mucolytic agents, 100:581-c 
and protein in gallbladder bile, 100: 
1724 
dissolution by E R C G , 100:1780-ss 
five-year incidence, ultrasonographic 
analysis, 100:790 
methyl tert-butyl ether dissolution of, 
gallbladder morphology, 100:1718 
physicochemical determinants of shock-
wave biliary lithotripsy, 100:222 
Gap junctions, intercellular coupling in 
intestinal smooth muscle, 100: 
1776-ss 
Gas microbubbles, acoustic cavitation, 
hepatic lesions (rabbit), 100:1345 
Gastric emptying, and gastroduodenal mo-
tility in duodenal ulcer disease, 100: 
892 
Gastrin 
in duodenal ulcer patients, Helicobacter 
pylori-associated release, 100:1571 
secretory kinetics of G cells, omeprazole 
effects (rat), 100:1187 
Gastrinoma, localization by arterial secre-
tin stimulation, 100:1472-ss 
Gastroenterology 
irritable bowel syndrome in office-based 
practice, 100:998 
Tomorrow's Doctors—The Path to Suc-
cessful Practice in the 1990's, 100: 
845-ss 
Gastrointestinal tract 
antroduodenal motility, enprostil effects, 
100:59 
cancer, somatostatin receptor imaging, 
100:1143-ss 
diabetes effects on cholinergic transmis-
sion (rat), 100:123 
galanin role, 100:1762-srr 
Immunology and Immunopathology of 
the Liver and Gastrointestinal Tract, 
100:1478-br 
motor dysfunction in dysautonomia as-
sociated with infectious mononucle-
osis, 100:252-cr 
neurohormonal factors in functional 
dyspepsia, 100:1311 
proliferating epithelial, immunohis-
tochemical labeling, 100:259 
pS2 and hSP genes as markers of mu-
cosal ulceration, 100:375 
push-enteroscopy for bleeding, 100: 
838-ss 
substance P receptors (cat), 100:1576 
Therapeutic Gastrointestinal Endoscopy, 
100:1782-br 
transit and l u m i n a l viscosity, hydrox-
ypropylmethylcellulose effect (dog), 
100:1217 
Gene expression 
i n cystic fibrosis, 100:843-ss 
p53, i n colon cancer, 100:842-ss 
pS2 and hSP, markers of mucosal ulcer-
ation of digestive tract, 100:375 
ras mutat ion, i n pancreatic adenocarci-
noma, 100:233-cr 
Genetic factors 
i n fami l ia l adenomatous polyposis, 100: 
1658 
inflammatory bowel disease i n chi ldren 
of both parents w i t h disease, 100: 
1638 
Geographic variation of inflammatory 
bowel disease i n United States, 100: 
143 
Glucagon 
and amino acid uptake by pancreas, 100: 
1095 
and bile acids i n liver cirrhosis, 
100:1671 
and hepatic energy charge and arterial 
ketone body ratio (rabbit), 100:1041 
Glucose metabolism dur ing starvation i n 
cirrhosis, 100:731 
Glutamine, and jejunal sodium and chlo-
ride absorption i n rotavirus enteritis 
(pig), 100:683 
Glycogen storage disease lb, neutrophi l 
dysfunct ion, and Crohn's-like col i -
tis, 100:549-cr 
Glycoproteins, colonic, i n monozygotic 
twins w i t h inflammatory bowel dis-
ease, 100:419 
Glycosylation, carbohydrate antigens i n 
pancreas, 100:1691 
Granulocyte-macrophage colony-stimu-
lating factor, and pancreas and gas-
tric carcinoma cell growth, 100:1338 
Granulomas, hepatic f ibr in-r ing, w i t h hep-
atitis A, 100:268 
Granulomatous vasculitis, i n Crohn's dis-
ease, 100:1279 
Growth i n chi ldren w i t h inflammatory 
bowel disease, collagen propeptides, 
100:971 
Hamartoma, ampullary, endoscopy of, 
100:795-cr 
Heat probe, for bleeding ulcers, 100:33, 
575-ss 
Heatstroke, exertional, and liver failure, 
100:1442-cr 
Helicobacter pylori 
epidemiology, effect of age, race, and so-
cioeconomic status, 100:1495 
and gastrin release i n duodenal ulcer 
patients, effects of bombesin and 
urea, 100:1571 
gastritis, and NSAID use, 100:1653 
infection, i n pernicious anemia, 100:328 
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Hemodynamics 
i n cirrhosis and ascites, effect of vaso-
pressin receptor blockade (rat), 100: 
494 
splanchnic, pulmonary hypertension i n 
portal hypertension, 100:520 
Hemorrhage 
f rom esophageal varices, vasopressin 
effects on portal pressure, 100:1411 
upper gastrointestinal, Meta-Analysis 
Workshop, 100:1481-c 
variceal 
portacaval shunt vs. endoscopic scle-
rotherapy, 100:1078 
predict ion of i n cirrhosis, 100:1332 





and hepatic fibrin-ring granulomas, 
100:268 
B virus 
chronic, interferon therapy, 100:277-
ss, 756 
D N A detection and direct sequencing, 
100:175 
fulminant , virus mutants defective i n 
precore region, 100:1087 
after interferon alfa therapy and liver 
transplantation, 100:263 
leukocyte adhesion molecules i n l iver, 
100:749 
mutants defective i n precore region, 
encoding of e antigen, 100:1087, 
1138-e 
reactivation, and cytotoxic therapy, 
100:182 
surface antigen, after renal transplan-
tation, 100:1432-cr 
vaccine-induced escape mutant , 100: 
578-ss 
C 
and hepatocellular carcinoma, 100: 
1145-ss 
screening of blood donors, 100:839-ss 
virus and antibody, 100:1144-ss 
chronic active, and Wilson's disease, 
100:762 
E antigen, neonatal tolerance to hepatitis 
B, 100:1475-ss 
experimental, tumor necrosis factor a, 
100:1153-c 
fu lminant Wilsonian, 100:1129 
herpes simplex virus, i n pregnancy, acy-
clovir treatment, 100:239-cr 
Hepatomegaly, and primary sclerosing 
cholangitis, 100:1710 
Hepatorenal syndrome, thromboxane A 2 
and prostacyclin product ion , 100: 
1069 
Herpes simplex virus, hepatitis i n preg-
nancy, 100:239-cr 
Hiatal hernia, and esophageal emptying , 
100:596 
Hippocampus, and prostaglandin E 2 an-
tisecretory effects (rat), 100:320 
Histamine, i n anaphylaxis-evoked intesti-
nal fluid secretion (rat), 100:922 
Histology 
microvascular anatomy of stomach 
(dog), 100:638 
v i tamin A hepatotoxicity, 100:1701 
Human immunodeficiency virus (HIV) 
infection 
i n chi ldren, m a l n u t r i t i o n and carbohy-
drate malabsorption, 
100:1296 
of enterocytes and mononuclear cells i n 
jejunal mucosa, 100:1521 
Hydroxypropylmethylcellulose, and gas-
trointestinal transit and l u m i n a l vis-
cosity (dog), 100:1217 
5-Hydroxytryptamine. See Serotonin. 
Hyperechogenicity, i n fatty l iver, 100:1678 
Hypergastrinemia, after partial gastric cor-
pectomy (rat), 100:311 
Hypersplenism, and auxi l iary heterotopic 
l iver transplantation, 100:1126 
Hypertension 
portal 
and auxil iary heterotopic l iver trans-
plantation, 100:1126 
and cirrhosis, i n adult Niemann-Pick 
disease, 100:567 
intestinal vascular sensitivity to vaso-
pressin (rat), 100:916 
noncirrhotic idiopathic , insu l in resis-
tance, 100:245-cr 
small intestinal transit (rat), 100:670 
pulmonary and portal , splanchnic hemo-
dynamics, 100:520 
Hypolactasia, adult, lactase expression by 
vi l lous enterocytes, 100:359 
Hypophosphatemia, and renal tubular 
dysfunct ion i n alcoholics, 100:502 
Hypothalamus, CCK-8 role i n colonic mo-
tor response to meal (rat), 100:441 
Ileum 
electrolyte transport, p H and cyclic A M P 
effects (rabbit, rat), 100:410 
first-pass clearance of bile acids, 100: 
1100 
innervation i n diabetes (rat), 100:1024 
noncholinergic membrane potential re-
sponses (guinea pig), 100:1006 
sodium chloride absorption (rabbit), 100: 
403 
Immune response, i n Crohn's disease, ef-
fect of zinc and malnutr i t ion , 100: 
1616 
Immunocytochemistry, calci tonin gene-
related peptide i n esophageal 
Langerhans cells, 100:560 
Immunofluorescence, intestinal brush bor-
der myosin I protein, 100:395 
Immunohistochemistry 
class I I antigens on intestinal epithelial 
cells, i n inflammatory bowel dise-
sae, 100:3 
granulomatous vasculitis i n Crohn's dis-
ease, 100:1279 
innervation of i leum and distal colon, in 
diabetes (rat), 100:1024 
labeling of proliferating cells i n digestive 
tract, 100:259 
lactase expression by vi l lous enterocytes 
i n adult hypolactasia, 100:359 
leukocyte adhesion molecules i n liver, i n 
hepatitis B virus infect ion, 100:749 
Immunology 
human intestine maturation as nude 
mouse xenograft, 100:89 
Immunology and Immunopathology of 
the Liver and Gastrointestinal Tract, 
100:1478-br 
pancreatic secretory protein (rat), 100: 
775 
Indomethacin 
and blood f low around gastric ulcers 
(rat), 100:1259 
and diphenhydramine, i n h i b i t i o n of ana-
phylaxis-evoked f l u i d secretion 
(rat), 100:922 
gastric damage 
leukotriene C 4 role (rat), 100:619 
prevention by antibody against GDI8 
leukocyte adhesion molecule (rab-
bit) , 100:878 
Infection 
Helicobacter pylori 
and NSAID use, 100:1653 
i n pernicious anemia, 100:328 
gastric, by spiral bacteria (monkey), 100: 
884 
Inflammation, intestine, sympathetic 
nerve funct ion (rat), 100:675 
Inflammatory bowel disease 
i n chi ldren, collagen propeptides as 
growth markers, 100:971 
class I I antigens i n intestinal epithelial 
cells, 100:3, 274-e 
colonic glycoproteins i n monozygotic 
t w i n s , 100:419 
epidemiology i n Sweden, 100:350 
geographic variat ion i n United States, 
100:143 
leukocyte adhesion molecules, expres-
sion by mucosal mononuclear ph-
agocytes, 100:150 
i n offspring of both parents w i t h disease, 
100:1638 
radical scavengers, 100:581-c 
Therapy of Inflammatory Bowel Disease: 
New Medical and Surgical Ap-
proaches, 100:580-ss 
Insulin resistance i n noncirrhotic idio-




and hepatitis B virus D N A i n liver, 
100:756 
therapy and liver transplantation, hep-
atitis B virus infection after, 100:263 
for chronic hepatitis B, 100:277-ss 
Interleukin l ß , expression by enterocytes 
i n colitis (rat), 100:1180 
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InterIeukin-3, and pancreas and gastric 
carcinoma cell growth, 100:1338 




of octapeptide SMS 201-995, 100:1544 
of oral hyperal imentation, i n very 
short bowel syndrome, 100:1502 
anaphylaxis-evoked f l u i d secretion, i n h i -
b i t i o n by diphenhydramine and i n -
domethacin (rat), 100:922 
brush border 
membrane vesicles, r ibof lavin trans-
port , 100:82 
myosin I protein, tissue dis tr ibut ion 
of, 100:395 
calcium transport across duodenum and 
je junum (rat), 100:47 
calc ium-binding protein, i n short bowel 
syndrome (rat), 100:1758 
decontamination, and bacterial peri toni-
tis, 100:477 
developing, lactase expression i n jeju-
n u m and i l e u m (rat), 100:388 
Diagnostic Pathology of the Intestinal Mu-
cosa: An Atlas and Review of Biopsy 
Interpretation, 100:1150-br 
electrolyte transport, neuromodulat ion 
by CCK-8 (guinea pig), 100:344 
epithelial cells, class I I molecules i n i n -
f lammatory bowel disease, 100:3, 
274-e 
epi thel ium, sodium-dependent nucleo-
side transport (rabbit), 100:1553 
food deprivation effects on CCK and so-
matostatin (rat), 100:909 
human, maturation as nude mouse xe-
nograft, 100:89 
inflamed, sympathetic nerve funct ion 
(rat), 100:675 
lactase expression, i n adult hypolactasia, 
100:359 
l i p i d digestion, and gastric electrical ac-
t iv i ty (cat), 100:380 
mot i l i ty , free radicals and platelet-acti-
vating factor i n endotoxin effects 
(rat), 100:946 
mucosal mast cells, dexamethasone ef-
fects (rat), 100:929 
permeability of subepithelial v i l lus and 
Peyer's patch foll icle capillaries, 
100:1172 
pouch ileoanal anastomosis and pouchi -
tis, stool levels of platelet-activating 
factor, 100:1509 
putrescine effects on v i tamin D (chick), 
100:113 
small 
amino acid transport i n brush border 
membrane vesicles, 1644 
IEC-18 epithelial cells, oxygen free 
radical in jury , 100:1533 
interst i t ial cells of Cajal, 100:1417 
transit i n portal hypertension (rat), 
100:670 
smooth muscle, intercellular coupling, 
100:1776-ss 
tight junctions, oligopeptide absorption 
(hamster), 100:719 
transplant, i ron absorption (rat), 100:370 
vascular sensitivity to vasopressin i n 
portal hypertension (rat), 100:916 
Iron 
absorption, i n intestinal transplant (rat), 
100:370 
inorganic, m u c i n role i n absorption of 
(rat), 100:129 
7-Irradiation, gastric ulcer production 
(rabbit), 100:1201 
Irritable bowel syndrome 
airway responsiveness to methacholine, 
100:68 
Irritable Bowel Syndrome: One Disease, 
Several or None? 100:1151-br 
i n office-based practice, 100:998 
personality assessment, 100:1154-c 
psychological treatment, 100:450 
sex differences i n M a n n i n g criteria, 100: 
591, 834-e 
Jejunum 
electrolyte transport, i n microvi l lus i n -
clusion disease, 100:811-cr 
HIV infect ion of enterocytes and mono-
nuclear cells, 100:1521 
sodium chloride absorption, glutamine 
effects, i n rotavirus enteritis (pig), 
100:683 
Ketones, arterial 
diurna l fluctuations, i n l iver dysfunc-
t ion , 100:1371 
and hepatic energy charge, glucagon ef-
fect (rabbit), 100:1041 
Ketotifen, and gastric mucosal damage by 
ethanol (rat), 100:1206 
Kidney 
calc ium-binding protein, i n short bowel 
syndrome (rat), 100:1758 
transplantation, hepatitis B surface anti-
gen redevelopment, 100:143 2-cr 
tubular dysfunct ion, and hypophos-
phatemia, i n alcoholics, 100:502 
Kinetics 
absorption of conjugated bile acids (rat), 
100:212 
glucagon effects on taurocholate uptake 
into hepatocytes, 100:1671 
secretory, of G cells, omeprazole effects 
(rat), 100:1187 
Lactase expression 
i n developing je junum and i l eum (rat), 
100:388 
by vi l lous enterocytes, i n adult hypolac-
tasia, 100:359 
Lactulose and sorbitol, for constipation i n 
elderly, 100:1474-ss 
Laminin 
i n chronic alcoholic l iver disease, 100: 
292-c 
turnover, subepithelial v i l lus and Peyer's 
patch foll icle capillaries (mouse), 
100:1172 
Laryngitis, reflux, proximal esophageal 
pH-metry, 100:305 
Laser therapy and intubat ion, endoscopic 
pal l ia t ion for malignant dysphagia, 
100:1303 
Leukocyte adhesion molecules 
CD18, monoclonal antibody against, pre-
vent ion of NSAID-gastropathy (rab-
bi t ) , 100:878 
i n l iver, i n chronic hepatitis B virus i n -
fection, 100:749 
mucosal, i n inflammatory bowel disease, 
100:150 
Leukotriene C 4 . i n gastric damage caused 
by necrotizing agents and i n d o m -
ethacin (rat), 100:619 
Linkage analysis, screening guidelines for 
f a m i l i a l adenomatous polyposis, 
100:1658 
Lipase, gastric, and dietary fat (rabbit), 
100:1582 
Lipids, intest inal , and gastric electrical ac-
t i v i t y (cat), 100:380 
Lipolysis, pancreatic enzymes i n frozen 
duodenal juice, 100:189 
Lithotripsy 
pulsed dye laser, of bile duct stones, 100: 
1730 
shock-wave bi l iary , physicochemical 
determinants of, 1 
Liver 
acoustic cavitation effects (rabbit), 100: 
1345 
a l b u m i n synthesis, i n tumor-bearing 
mice, role of anorexia and n u t r i t i o n , 
100:938 
blood flow, reciprocity not proven, 100: 
1483-c 
bromodeoxyuridine uptake, i n primary 
b i l i a r y cirrhosis, 100:725 
cholesterol metabolism i n Crohn's dis-
ease, ileal resection, 100:1046 
cytochrome P450IA2 distr ibut ion, 100: 
1487-c 
developing, Cu-Zn and M n superoxide 
dismutases (rat), 100:1062 
energy metabolism, and arterial ketone 
body ratio, glucagon effect (rabbit), 
100:1041 
fatty 
hypoechoic lesions, 100:1678 
and intrahepatic cholestasis, of preg-
nancy, 100:1123-cr 
recurrent acute, of pregnancy, and 
fat ty acid oxidation defect i n off-
spring, 100:544-cr 
f i b r i n - r i n g granulomas, and hepatitis A, 
100:268 
hepatocytes and intrahepatic bile duct 
ep i the l ium, 100:582-c 
Immunology and Immunopathology of 
the Liver and Gastrointestinal Tract, 
100:1478-br 
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leukocyte adhesion molecules, i n 
chronic hepatitis B virus infect ion, 
100:749 
necrosis, ursodeoxycholate conjugate 
effects (rat), 100:203 
regeneration, and monoclonal antibodies 
to bromodeoxyuridine, 100:1135 
sex hormone receptors i n males, effect of 
portal-systemic shunt ing, 100:168 
i n small bowel bacterial overgrowth, ef-
fects of metronidazole and tetracy-
cline (rat), 100:513 
Textbook of Liver and Biliary Surgery, 
100:1478-br 
transplantation 
and Crigler-Najjar syndrome, 100: 
279-ss 
and erythropoietic protoporphyria , 
100:1753-cr 
heterotopic, and hypersplenism and 
portal hypertension, 100:1126 
and interferon alfa therapy, hepatit is B 
virus infection after, 100:263 
v i tamin A hepatotoxicity, 100:1701 
zonal heterogeneity and cell polar i ty , 
after bile drainage (rat), 100:1054 
Liver disease 
alcoholic, biological index for detection 
i n drinkers, 100:1397 
carcinoma, and hepatitis C virus , 100: 
1145-ss 
chronic alcoholic, l a m i n i n and procolla-
gen i n , 100:292-c 
cirrhosis, glucagon effects on bile acids, 
100:1671 
in cystic fibrosis, bile acid treatment, 
100:1476-ss 
decompensated, thromboxane A 2 and 
prostacyclin product ion , 100:1069 
diurnal fluctuations of arterial ketone 
body ratio, 100:1371 
failure 
i n exertional heatstroke, 100:1442-cr 
prothrombin time, 100:1480-c 
rapid progression, 100:1462-cc 
fulminant Wilsonian hepatitis identif ica-
t ion , 100:1129 
hepatic encephalopathy and zinc defi-
ciency, 100:1114-cr 
hepatobiliary cryptosporidiosis and cy-
tomegalovirus infect ion, 100: 
1743-cr 
Hepatology: A Textbook of Liver Disease, 
100:1150-br 
hydat id cysts, management by aspiration 
and alcohol, 100:290-c 
liver cirrhosis, spontaneous hepatofugal 
portal f low, 100:160 
Progress in Liver Diseases. Volume IX, 
100:846-br 
vi tamin A release, portacaval shunt as 
model, 100:1379 
Luminal acid, and p H i n oxynticopeptic 
cells i n gastric mucosa (frog), 100: 
606 
Lymphangiectasia, intestinal , ant ip lasmin 
therapy, 100:1152-c 
Lymphocytes, T, i n primary bi l iary cirrho-
sis, 100:822 
Major histocompatibility complex, class I I 
expression on enterocytes, 100: 
274-e 
Malnutrition 
i n chi ldren w i t h HIV infect ion, 100:1296 
and immunological funct ion i n Crohn's 
disease, 100:1616 
Manning criteria, sex differences i n i rr i ta-
ble bowel syndrome, 100:591, 834-e 
Manometry 
esophageal emptying w i t h hiatal hernia, 
100:596 
and p H , ambulatory, of esophagus, 100: 
1630 
Mast cells, mucosal, dexamethasone ef-
fects (rat), 100:929 
Melanosis of esophagus, 100:13 
Membranes 
i leum, substance P antagonism (guinea 
pig), 100:1006 
stomach, angiotensin-converting enzyme 
(rabbit), 100:25 
6-Mercaptopurine, i n adolescents, 100: 
1156-c 
Methacholine, airway responsiveness to, 
i n irritable bowel syndrome, 100:68 
Methyl terr-butyl ether, gallstone dissolu-
t ion, and gallbladder morphology, 
100:1718 
Metronidazole, for hepatic in jury i n small 




colonic muscle contraction (rabbit), 
100:75 
interst i t ial cells of Cajal of small intes-
tine, 100:1417 
omeprazole effects on gastric endo-
crine cells, 100:1563 
subepithelial v i l lus and Peyer's patch 
foll icle capillaries (mouse), 
100:1172 
electron and l ight 
gallbladder after gallstone dissolution 
w i t h methyl terf-butyl ether, 100: 
1718 
gastric infection by spiral bacteria 
(monkey), 100:884 
human intestine maturat ion as nude 
mouse xenograft, 100:89 
hypertrophic smooth muscle i n esoph-
ageal obstruction (opossum), 100: 
853 
melanosis of esophagus, 100:13 
mucosal mast cell depletion by dexam-
ethasone (rat), 100:929 
mult i focal colitis and chronic diar-
rhea, 100:458 
neoplastic colonic epithelial cells (rat), 
100:692 
fluorescence 
intestinal absorption of SMS 201-995, 
100:1544 
vagal fibers for gastric acid secretion 
(rat), 100:627 
l ight 
inter leukin l ß expression by entero-
cytes i n colitis (rat), 100:1180 
leukocyte adhesion molecule anti-
body, prevention of NSAID-gastrop-
athy (rabbit), 100:878 
microsporidiosis and response to oc-
treotide, 100:271 
pancreatic cancer growth and me-
tastases (hamster), 100:529 
See also Immunohistochemistry. 
Microsporidiosis, l ight microscopic diag-
nosis, response to octreotide, 100: 
271 
Microvillus inclusion disease, jejunal 
electrolyte transport, 100:811-cr 
Microwave, and foodborne hepatitis A, 
100:577-ss 
Migrating motility complex, duodenal 
cross-sectional area, 100:281-ss 
Mitochondria, autoantigens i n primary 
bi l iary cirrhosis, 100:822 
Mononuclear cells, je junal, H I V infection, 
100:1521 
Mononucleosis, infectious, w i t h dysauto-
nomia, gastrointestinal motor dys-
funct ion , 100:252-cr 
Morbidity and mortality 
geographic variat ion of inflammatory 
bowel disease, 100:143 
hepatitis B virus reactivation, and cyto-
toxic therapy, 100:182 
Motilin, and interdigestive gastric contrac-




phy, enprostil effects, 100:59 
colonic 
i n acute colitis (dog), 100:954 
and hypothalamic CCK-8 (rat), 100: 
441 
i n mental stress, release of corticotro-
pin-releasing factor (rat), 100:964 
enteric neuronal autoantibodies i n pseu-
doobstruction w i t h 
small-cell lung carcinoma, 100:137 
gastric 
peptide YY i n h i b i t i o n of (guinea pig), 
100:865 
and small bowel , i n funct ional dys-
pepsia, 100:1311 
gastroduodenal, i n duodenal ulcer dis-
ease, 100:892 
intestinal 
free radicals and platelet-activating 
factor i n endotoxin effects (rat), 100: 
946 
peptide E effects, opioid receptor 
changes (guinea pig, mouse, dog, 
rat), 100:1603 
Mucin 
and absorption of inorganic i ron and 
metal cations (rat), 100:129 
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epithelial , and inf lammatory damage, 
100:284-ss 
secretagogue activity of Entamoeba his-
tolytica i n colon (rat), 100:986 
Multiple sclerosis, anorectal sensory and 
motor funct ion , 100:465 
Muscle 
colon, anatomic correlation w i t h con-
tractions (rabbit), 100:75 
smooth 
calc ium channels, 100:1448-srr 
gastric, dopamine receptors (guinea 
pig), 100:1224 
hypertrophy i n esophageal obstruction 
(opossum), 100:853 
Muscular dystrophy, myotonic , anal 
sphincter, 100:424 
Mylanta, i n postoperative stress ulcers, 
after coronary artery bypass surgery, 
100:1515 
Myosin I protein, intestinal brush border 
dis t r ibut ion of, 100:395 
National Ambulatory Medical Care Sur-
veys, i rr i table bowel syndrome i n 
office-based practice, 100:998 
Neoplasia, colonic epithelial cells (rat), 
100:692 
Nerves 
adrenergic and peptidergic, i n i l eum and 
distal colon, i n diabetes (rat), 100: 
1024 
cholinergic, diabetes effect on intestinal 
transmission (rat), 100:123 
colonic, tachykin in effects (cat), 100:431 
sympathetic, i n inflamed intestine (rat), 
100:675 
Neurokinin A, i n colonic tissues and 
nerves (cat), 100:431 
Neuropathy, erythropoietic protoporphy-
ria after liver transplantation, 100: 
1753-cr 
Neuropeptides, galanin i n gastrointestinal 
tract, 100:1762-srr 
Neurotransmitters, and ion transport i n 
distal colon (pig), 100:703 
Neutrophils 
cytoplasmic antibodies, i n ulcerative 
coli t is , 100:1385, 1469-e, 1590 
dysfunct ion in glycogen storage disease 
lb , 100:549-cr 
Niemann-Pick disease, w i t h cirrhosis and 
portal hypertension, 100:567 
Nonsteroidal antiinflammatory drugs 
(NSAIDs) 
and colonic strictures, 100:1119-cr 
and Helicobacter pylori infect ion, 100: 
1653 
Norepinephrine, and ion transport i n dis-
tal colon (pig), 100:703 
Norfloxacin, intestinal decontamination, 
and bacterial peritonit is , 100:477 
Nucleosides, sodium-dependent transport, 
i n intestinal epi the l ium (rabbit), 
100:1553 
Nutrition 
and anorexia, a l b u m i n synthesis i n t u -
mor-bearing mice, 100:938 
and chronic alcohol ingestion, 100:295-c 
Dietary Fiber Research, 100:1782-br 
energy metabolism i n ascites and liver 
cirrhosis, 100:738 
food deprivation, and intestinal CCK and 
somatostatin (rat), 100:909 
oral hyperalimentation i n very short 
bowel syndrome, 100:1502 
substrate influence on volatile metabo-
lites, 1597 
See also M a l n u t r i t i o n . 
Obesity 
intragastric balloons, 100:847-c 
metabolic rate, 100:1146-ss 
Octreotide, for microsporidiosis, 100:271 
Oligopeptide, i n intestinal tight junctions 
at glucose-induced dilatations (ham-
ster), 100:719 
Omeprazole 
and cytochrome P-450 induct ion , 100: 
1157-c, 1488-c 
for duodenal ulcer relapse, dosage com-
parison, 100:663 
and nocturnal intragastric acidity, 100: 
873 
and secretory kinetics of G cells (rat), 
100:1187 
and ultrastructure of gastric endocrine 
cells, 100:1563 
Opioid receptors, peptide E effect on gut 
m o t i l i t y (guinea pig , mice, dog, rat), 
100:1603 
Ornithine decarboxylase 
i n duodenal mucosa, stress effects (rat), 
100:333 
i n rectal mucosa, hyperplastic and ade-
nomatous polyps, 100:1528 
2-Oxo-acid dehydrogenases, i n primary 
bi l iary cirrhosis, 100:822 
Oxygen, free radical in jury of IEC-18 small 
intestinal epithelial cells, 100:1533 
Pancreas 
adenocarcinoma, diagnosis by ras gene 
mutat ion, 100:233-cr 
amino acid uptake, effect of pancreatic 
polypeptide, trryrotropin-releasing 
hormone, and glucagon, 100:1095 
cancer, patterns of growth and me-
tastases (hamster), 100:529 
carbohydrate antigens, 100:1691 
carcinoma cell growth, s t imulat ion by 
inter leukin 3 and granulocyte-mac-
rophage colony-st imulating factor, 
100:1338 
and C C K receptor blockade, 100:1683 
endogenous and exogenous st imulat ion 
of secretion, interaction of chol in-
ergic system and CCK, 100:537 
endoscopic transpapillary drain , for dis-
rupted duct and peripancreatic f l u i d 
collections, 100:1362 
enzyme protection i n frozen duodenal 
juice, 100:189 
exocrine function, thyroid effects, 100: 
1392 
hypercalcemia and pancreatic lithogene-
sis, 100:291-c 
Pancreatic duct, short-term obstruction 
(rat), 100:196 
Pancreatic elastase 1, sterol-binding ca-
pacity, 100:768 
Pancreatic polypeptide, and amino acid 
uptake by pancreas, 100:1095 
Pancreatitis 
and diabetes, retinopathy in, 100:585-c 
secretory protein associated with (rat), 
100:775 
Penicillamine, for Wilson's disease in 
chronic active hepatitis, 100:762 
Pepsinogen 
ethanol effect, calcium channel in gastric 
chief cells (guinea pig), 100:17 
group I, smoking effects, 100:288-c 
Peptide E, and opioid receptors, effect on 
gut motility (guinea pig, mouse, dog, 
rat), 100:1603 
Peptide Y Y , and gastric motility, mecha-
nism of action in inhibition of 
(guinea pig), 100:865 
Peritonitis, bacterial 
with cirrhosis and ascites, animal model 
(rat), 100:489 
and intestinal decontamination, 100:477 
Permeability, subepithelial villus and Pey-
er's patch follicle capillaries, 100: 
1172 
PGA index, alcoholic liver disease in 
drinkers, 100:1397 
pH 
and gastroduodenal motility, in duode-
nal ulcer disease, 100:892 
and ileal electrolyte transport (rabbit, 
rat), 100:410 
intracellular, gastric protection by sur-
face-active phospholipid (Necturus), 
100:38 
and manometry, ambulatory, of esopha-
gus, 100:1630 
of oxynticopeptic cells in gastric mu-
cosa, effect of luminal acid (frog), 
100:606 
of proximal esophagus, in reflux laryngi-
tis, 100:305 
Phagocytes, mucosal mononuclear, in in-
flammatory bowel disease, expres-
sion of leukocyte adhesion mole-
cules, 100:150 
Pharmacology, of calcium channels in 
smooth muscle, 100:1448-srr 
Phenobarbital response in Crigler-Najjar 
disease, 100:783 
Phosphatidylinositol diphosphate, and 
calcium channels in smooth muscle, 
100:1448-srr 
Phospholipid 
surface-active, gastric protection by 
(Necturus), 100:38 
surfactant, prostaglandin E 2-induced se-
cretion by gastric mucous cells 
(dog), 100:1232 
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Photosensitivity, erythropoietic protopor-
phyria after l iver transplantation, 
100:1753<cr 
Platelet-activating factor 
and free radicals, i n endotoxin effects on 
intestinal m o t i l i t y (rat), 100:946 
stool levels, i n pouch ileoanal anastomo-
sis and pouchit is , 100:1509 
Polyamines, in duodenal mucosa, stress 
effects (rat), 100:333 
Polymerase chain reaction 
hepatitis B virus genome detection and 
direct sequencing, 100:175 
i n pancreatic adenocarcinoma, ras gene 
mutat ion, 100:233-cr 
Polyposis, famil ial adenomatous, screen-




and adenomatous, orni thine decarbox-
ylase and tyrosine kinase i n rectal 
mucosa, 100:1528 
colon, and adenomas, 100:1142-ss 
i n sigmoidoscopy, markers for p r o x i -
mal adenomas, 100:564 
Ponalrestat, and cholinergic transmission 
i n i leum, i n diabetes (rat), 100:123 
Portal vein, extrahepatic aneurysm, 100: 
818-cr 
Pregnancy 
acute fatty liver 
and fatty acid oxidat ion defect i n off-
spring, 100:544-cr 
and intrahepatic cholestasis, 100: 
1123-cr 
herpes simplex virus hepatitis, 100: 
239-cr 
Procollagen, N-terminal type III, i n 
chronic alcoholic liver disease, 100: 
292-c 
Proctalgia fugax, hereditary internal anal 
sphincter myopathy, 100:805-cr 
Prostacyclin i n liver disease and hepatore-
nal syndrome, 100:1069 
Prostaglandin E 2 
antisecretory effects, central control (rat), 
100:320 
and bicarbonate, protection against acid-
induced electrical conductance i n 
duodenum (guinea pig), 100:648 
and indomethacin effect on blood f low to 
gastric ulcers (rat), 100:1259 
and surfactant phosphol ip id secretion by 
gastric mucous cells, 100:1232 
Protein 
calcium-binding, intestinal and renal, i n 
short bowel syndrome (rat), 100: 
1758 
ca lmodul in-binding, brush border myo-
sin I, intestinal dis tr ibut ion, 100:395 
high total, i n gallbladder bile, role i n for-
mation of cholesterol gallstones, 
100:1724 
pancreatic secretory, associated w i t h 
pancreatitis (rat), 100:775 
Prothombin time, i n fu lminant hepatic 
failure, 100:1480-c 
Protoporphyria, erythropoietic, after liver 
transplantation, 100:1753-cr 
Psychology, personality i n nonulcer dys-
pepsia and irritable bowel syn-
drome, 100:1154-c 
Psychotherapy, for irritable bowel syn-
drome, 100:450 
Putrescine, and intestinal v i tamin D 
(chick), 100:113 
Race, and Helicobacter pylori infection, 
100:1495 
Ranitidine 
and nocturnal intragastric acidity, 100: 
873 
i n postoperative stress ulcers, after coro-
nary artery bypass graft surgery, 
100:1515 
Receptors 
calc ium channels i n smooth muscle, 
100:1448-srr 
CCK, pancreatic and bi l iary funct ion , 
100:1683 
and dopamine effects on gastric smooth 
muscle (guinea pig), 100:1224 
hepatic sex hormone, effect of portal-
systemic shunting i n males (rat), 
100:168 
opioid, peptide E effect on gut m o t i l i t y 
(guinea pig, mouse, dog, rat), 100: 
1603 
serotonin, and m o t i l i n regulation of i n -
terdigestive gastric contractions 
(dog), 100:901 
substance P, i n gastrointestinal tract 
(cat), 100:1576 
vasopressin, blockade effects on arterial 
pressure i n cirrhosis and ascites 
(rat), 100:494 
Rectum 
adenocarcinoma, i n persons under 40, 
100:1033 
orni thine decarboxylase and tyrosine 
kinase, in hyperplastic and adenom-
atous polyps, 100:1528 
Redox potential, arterial ketone body ratio, 
d iurna l f luctuations i n l iver disease, 
100:1371 
Respiration, airway responsiveness to 
methacholine, i n irritable bowel 
syndrome, 100:68 
Retinopathy i n pancreatic diabetes, 100: 
585-c 
Rhabdomyolysis, l iver failure i n exertional 
heatstroke, 100:1442-cr 
Riboflavin transport i n human intestinal 
brush border membrane vesicles, 
100:82 
Risk factors, hepatitis B virus reactivation, 
and cytotoxic therapy, 100:182 
RNA, messenger 
for lactase-phlorizin hydrolase, i n devel-
oping intestine (rat), 100:388 
sucrase-isomaltase, i n colon adenocarci-
nomas, 100:1266 
Sarcoma, granulocytic, of colon, 100: 
555-cr 
Screening tests 
colonoscopy, in asymptomatic average-
risk persons with negative fecal oc-
cult blood tests, 100:64 
familial adenomatous polyposis, 100: 
1658 
VIP, and diarrhea. 100:99 
Selected Summaries 
Anti-HCV screening of blood donors: 
The impact in Spain, 100:839 
Bicarbonate secretory breakdown: Expla-
nation for increased incidence of 
duodenal ulcer with age? 100:1471 
Cajal has the nerve to set the pace in the 
colon, 100:572 
Colon cancer and the p53 oncogene, 100: 
842 
Colonoscopic surveillance for cancer in 
patients with chronic ulcerative 
colitis: Is it working? 100:570 
Crigler-Najjar syndrome type 1 expli-
cated—Thanks to liver transplanta-
tion, 100:279 
Cystic fibrosis: Another use for URSO? 
100:841 
Duodenal ulcer disease—To heal or to 
cure? 100:573 
Endoscopic therapy for peptic ulcer 
hemorrhage: Heater probe and alco-
hol injection, 100:575 
Enteroscopy: Exploring the final frontier, 
100:838 
An epithelial mucin may protect the epi-
thelium from inflammatory damage, 
100:284 
E R C G : The final frontier in gallstone dis-
solution? 100:1780 
Formation of unusual trihydroxy bile 
acids in humans: Mechanism for 
decreasing hydrophobicity and toxic 
potential of bile acids? 100:283 
Hepatitis A: More food for thought, 100: 
577 
Hepatitis B virus: The Houdini of hepa-
tology? 100:578 
Hepatitis C virus and hepatocellular car-
cinoma: Additional evidence of a 
causal link, 100:1145 
Hepatitis C—the virus as well as the an-
tibody, 100:1144 
Hepatitis E antigen and neonatal immu-
nologic tolerance to hepatitis B, 100: 
1475 
Hurray for brand X, 100:1474 
Hyperplastic colon polyps do not predict 
adenomas, 100:1142 
Impediments to impedance, 100:281 
Inhibition of gastric acid secretion by 
Mj-receptor antagonists, 100:1777 
Interferon in clinically stable replicative 
chronic hepatitis B: Good news for 
some, 100:277 
Interleukin-10 and counting... 100:1778 
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Liver dysfunct ion i n cystic f ibros is— 
Beneficial effect of bile acid treat-
ment, 100:1476 
Localization of gastrinoma using arterial 
secretin s t i m u l a t i o n — W o r t h w h i l e 
or passing fancy? 100:1472 
Lucifer exposes coupling, 100:1776 
More news on the cystic fibrosis gene, 
100:843 
Prophylaxis for variceal bleeding, 100: 
1778 
I n vivo somatostatin receptor imaging i n 
the detection and treatment of gas-
trointestinal cancer, 100:1143 
Weight reduct ion and metabolic rate: 
Good news for obese patients? 100: 
1146 
Sequence analysis 
D N A , hepatitis B virus genome, 100:175 
and fu lminant hepatitis B, 100:1087 
Serotonin receptors, and m o t i l i n regula-
t ion of interdigestive gastric contrac-
tions (dog), 100:901 
Sex differences 
gallstone incidence, 100:790 
i n M a n n i n g criteria i n irritable bowel 
syndrome, 100:591, 834-e 
pr imary sclerosing cholangitis w i t h u l -
cerative colitis , 100:1319 
Sex hormones, hepatic receptors i n males, 
effect of 
portal-systemic shunt ing (rat), 100:168 
Shock waves, acoustic cavitation, hepatic 
lesions (rabbit), 100:1345 
Short bowel syndrome 
intestinal absorption of oral hyperal i -
mentation, 100:1502 
intestinal and renal ca lc ium-binding 
protein (rat), 100:1758 
Shunts 
distal splenorenal, portal perfusion i n 
alcoholism, 100:799-cr 
portacaval 
vs. endoscopic sclerotherapy, for va-
riceal hemorrhage, 100:1078 
v i tamin A release i n l iver disease (rat), 
100:1379 
portal-systemic, and hepatic sex hor-
mone receptors i n males (rat), 100: 
168 
Sigmoidoscopy 
Flexible Sigmoidoscopy: Techniques and 
Utilization, 100:845-br 
hyperplastic polyps as markers for prox i -
mal adenomas, 100:564 
Sleep, and anal mot i l i ty , 100:1016 
Small bowel bacterial overgrowth, he-
patic in jury , metronidazole and tet-
racycline effects (rat), 100:513 
Smoking, and pepsinogen group I , 100: 
288-c 
Socioeconomic status, and Helicobacter 
pylori infect ion, 100:1495 
Sodium chloride absorption 
i n i l eum, effects of acid-base variables 
(rabbit), 100:403 
i n je junum, glutamine effects, i n rotavi-
rus enteritis (pig), 100:683 
Somatostatin 
analogue SMS 201-995, intestinal ab-
sorption, 100:1544 
intestinal, dur ing food deprivation (rat), 
100:909 
receptor imaging, i n gastrointestinal can-
cer, 100:1143-ss 
i n VIP effects on gastric acid secretion 
(mouse), 100:1195 
Sorbitol and lactulose, for constipation i n 
elderly, 100:1474-ss 
Special Reports and Reviews 
Calcium channels i n smooth muscle, 
100:1448 
Primary bi l iary cirrhosis: Paradigm or 
paradox for auto immuni ty , 100:822 
Role of galanin i n the gut, 100:1762 
Sphincter 
anal 
dur ing fasting, feeding, and sleep, 100: 
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Role of High Total Protein in Gallbladder 
Bile in the Formation of Cholesterol 
Gallstones 
DIETER JÜNGST, THOMAS LANG, CHRISTOPH VON RITTER, 
and GUSTAV PAUMGARTNER 
Department of Medicine I I , Ludwig-Maximil ians-Univers i ty of M u n i c h , K l i n i k u m Grosshadern, 
M u n i c h , Germany 
While it is generally accepted that cholesterol super-
saturation of bile is of key importance in the rapid 
formation of cholesterol crystals, the role of total 
biliary protein and pH in the pathogenesis of choles-
terol gallstones is less well understood. The relation 
of cholesterol saturation, total protein, and pH was 
studied in 73 gallbladder bile samples with and 35 
gallbladder bile samples without cholesterol crys-
tals. In samples containing crystals, a trend to 
higher values of cholesterol and to a higher choles-
terol saturation index was observed. However, signif-
icantly (P = 0.02) higher concentrations of total 
protein were found in samples with crystals 
[0.80 ± 0.40 g/dL (8.0 ± 4.0 g/L)] than in samples 
without crystals [0.63 ± 0.26 g/dL (6.3 ± 2.6 g/L)]. 
Moreover, of 22 bile samples with total protein 
concentrations > 10.0 g/L, cholesterol crystals were 
detected in all but 2. Total lipids, bile acids, phospho-
lipids, and pH values were not significantly different 
in the two groups of bile samples. It was concluded 
that high biliary protein concentrations are fre-
quently associated with cholesterol crystals and 
may, therefore, be a possible risk factor in the 
pathogenesis of cholesterol gallstones. 
In recent years, nonsurgical procedures for the treatment of cholesterol gallstones have gained 
importance (1-4). These methods are hampered by a 
high rate of stone recurrence after successful dissolu-
tion therapy (5-8). Studies of the factors predisposing 
to gallstone formation may yield clues about the risk 
of stone recurrence. In gallbladder bile from patients 
with cholesterol gallstones, cholesterol crystal forma-
tion is accelerated compared with equally supersatu-
rated bile from patients with pigment stones or healthy 
controls (9,10). This suggests that factors other than 
cholesterol supersaturation play a role in gallstone 
formation. Different bile proteins appear to promote 
cholesterol nucleation (11-14). Furthermore, it has 
been postulated that quantitative abnormalities in 
total biliary protein may favor gallstone formation 
(15,16). 
Recently, Shiffman and Moore (17) have reported a 
defective acidification of gallbladder bile in gallstone 
patients. This defect renders bile supersaturated with 
C a C 0 3 and may lead to precipitation of crystals of 
calcium carbonate, which could act as nidus for 
cholesterol stones. Changes in pH may also affect the 
conformation of proteins and by this mechanism 
change their properties with respect to their nucleat-
ing activity. 
Therefore, in addition to cholesterol supersatura-
tion, changes in biliary protein concentration and pH 
may facilitate the development of cholesterol gall-
stones. These considerations prompted us to compare 
total protein concentrations and pH in gallbladder 
bile samples with and without cholesterol crystals. 
Materials and Methods 
Patients and Collection of Bile 
One hundred eight patients, 78 women and 30 men, 
who underwent elective cholecystectomy for symptomatic 
gallstone disease were included in the study. Fourteen 
patients in whom cystic duct obstruction was suspected 
because of white gallbladder bile and total lipid concentra-
tions <1 g/dL (<10 g/L) were excluded from the study. 
During surgery, bile was aspirated with an 18-gauge needle 
from the gallbladder. Because of the known stratification of 
Abbreviations used in this paper: BSA, bovine serum albumin; 
T C A , trichloracetic acid. 
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human gallbladder bile (18), particular care was taken to 
collect gallbladder bile completely. Clamping of the gallblad-
der wall before bile aspiration was avoided to prevent 
mucosal damage. Stones were removed with the gallblad-
der, washed with distilled water, dried, and weighed. The 
cholesterol content of the gallbladder stones was measured 
chemically after extraction with organic solvents and ex-
pressed as percentage of dry weight. 
Biliary Microscopy and pH Measurement 
After collection, bile samples were mixed thor-
oughly and one drop of bile was immediately examined by 
polarized light microscopy for cholesterol crystals. Because 
small numbers of crystals may be overlooked by the micro-
scopic examination of unspun bile, the sediment of the bile 
samples was reexamined for cholesterol crystals after ultra-
centrifugation (100,000 x g for 2 hours). Parallel to micros-
copy, pH was measured in fresh anaerobic bile samples 
with a pH-sensitive electrode that was calibrated at 22°C 
using hydrogen phosphate and tetraborate buffers at pH 
6.86 and pH 9.18, respectively. The bile samples were 
maintained in closed syringes until analysis to avoid loss of 
C 0 2 to the atmosphere. Under these conditions, pH values 
remained constant to within ± 0 . 1 during the 1-hour obser-
vation time. 
Analysis of Biliary Lipids 
For the analysis of bile lipids, duplicate aliquots 
were stored at - 7 0 ° C until determination. Cholesterol con-
centration was determined colorimetrically with the Lieber-
mann-Burchard reaction after extraction of a 1-mL metha-
nolic bile sample with petrol ether (19). The recovery of 
biliary cholesterol after extraction exceeded 90%, with an 
interassay variance of < 5%. Phospholipids were measured 
as total biliary phosphate after hydrolysis with sulfuric acid 
at 150°C using the colorimetric assay described by Fiske and 
Subbarow (20) (interassay variance, <5%). The contribu-
tion of inorganic phosphate to total biliary phosphate is 
negligible ( < 5%; unpublished observation); therefore, total 
phosphate adequately reflects lipid bound phosphate. Total 
bile salt concentrations were determined by a modified 
3-hydroxysteroid dehydrogenase method (21). For this as-
say, methanolic bile solutions were prepared by diluting 0.1 
mL of bile to a volume of 1.0 mL with methanol. The 
reaction mixture contained 1 mL of 1 mol/L glycine buffer 
(pH 9.4) containing ethylenediaminetetraacetic acid (EDTA) 
(5.6 mmol/L) and hydrazine sulfate (0.4 mmol/L), 0.1 mL of 
NAD solution (5.4 mmol/L), 0.1 mL of hydroxy steroid 
dehydrogenase solution (0.7 U/mL), and 0.02 mL of metha-
nolic bile solution. The mixture was incubated at 26°C for 1 
hour and the extinction measured at 340 nm against 
appropriate blanks (interassay variance, <5%). 
The cholesterol saturation index of each sample was 
calculated according to the method of Carey (22) by divid-
ing the cholesterol concentration by the maximum choles-
terol solubility and corrected for the total lipid content of 
each individual bile sample. 
Analysis of Biliary Protein 
Biliary proteins were precipitated from bile by the 
addition of 7% trichloracetic acid (TCA) (100 pX bile in 2 
mL TCA). The mixture was kept at 4°C for at least 12 hours 
and then centrifuged at 1000 x g for 10 minutes. The pellet 
was resuspended in 2 mL of 7% T C A and recentrifuged. The 
precipitated protein was washed twice in 2 mL of cold 
ether-ethanol 3:1 (vol/vol). After a final centrifugation at 
1000 x g for 10 minutes, the organic solvents were decanted 
and the remaining protein pellet was dissolved in 500 uX of 
I N NaOH. This solution was kept at 37°C for 1 hour to 
ensure complete dissolution of the proteins. Bovine serum 
albumin (Bio-Rad, Richmond, CA) was used as standard 
protein. Standards with protein concentrations ranging 
from 1.0 to 20 g/L were prepared like the native bile 
samples. For the Lowry procedure (23), 0-, 10-, 20-, 30-, 40-, 
and 50-uX aliquots of the 500-pX I N NaOH/protein solu-
tions were diluted with I N NaOH to an equal volume of 100 
uX. After addition of 1.0 mL of the alkaline reagent, the 
mixture was incubated for 10 minutes. Two hundred 
microliters of Folin reagent/H20 (1:1) were added and 
absorbance was read at 750 nm after an additional 30 
minutes of incubation. The protein content of the bile 
samples was expressed as the mean value of five measure-
ments at different dilutions (1:10-1:50). By this method, an 
interassay variance of < 5% was determined. The modified 
Lowry procedure described above was compared with a 
fluorometric assay for biliary protein determination (24-
26). For this purpose five gallbladder bile samples were 
"spiked" with bovine serum albumin (BSA) and human 
immunoglobulin G (IgG) in five different concentrations 
(0.5-7.5 g/L) and the recovery measured using both Lowry 
and fluorometric assays. For the fluorometric assay the final 
protein pellet was dissolved in 500 u.L borate buffer (0.2 
mol/L, pH 8.5) and incubated for 1 hour at 37°C. Ten- and 
30-uX aliquots were diluted up to 200 uX with borate buffer 
(0.2 mol/L, pH 8.5). One minute after addition of 100 uX of 
fluorescamine solution (0.03% in acetone) the reaction 
mixture was diluted with 3.5 mL H 2 0 and fluorescence was 
determined at 390 nm on a fluorometer (Fluorescence 
Spectrophotometer; Perkin-Elmer, Norwalk, CT) . The final 
dilution of native bile was 1:617-1:1850 in the fluorometric 
assay and 1:10-1:50 in the modified Lowry assay. 
Sta tistical An alysis 
All results are expressed as mean ± SD or median 
and range. Student's unpaired t test was used for group 
comparison with the level of statistical significance set at 
P < 0.05. Spearman's rank correlation coefficients were 
calculated using the method of least squares. 
Results 
Cholesterol Crystals 
Gallbladder bile samples obtained from 108 
patients during cholecystectomy were divided into 
two groups according to the presence or absence of 
microscopic cholesterol crystals. Seventy-three pa-
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Figure 1. Mean ± SD total protein concentration in gallbladder 
biles "spiked" with different concentrations of BSA and IgG as 
measured by the Lowry (•) or fluorometric (O) method (n = 5). 
tients, 58 women and 15 men, had multiple choles-
terol crystals of typical shape both in their native bile 
samples and in the sediment after ultracentrifugation. 
The cholesterol content of the stones in this group of 
patients varied from 36% to 99% (median, 70.4%). In 
the remaining 35 patients, 20 women and 15 men, no 
cholesterol crystals were detected. In this group stone 
analysis showed a cholesterol content between 0 and 
76% (median, 9.6%). In 84 samples of patients with 
cholesterol stones (>50% cholesterol), crystals were 
found in 84% (70 patients). In all 18 samples of 
patients with pigment stones (<10% cholesterol), 
crystals were absent. In 3 of 6 bile samples from 
patients with mixed stones (10%-50% cholesterol), 
cholesterol crystals were found. 
Analysis of Protein, Lipids, and pH in Bile 
Figure 1 compares total protein concentrations 
determined in five native bile samples using the 
Lowry procedure and a fluorometric method as de-
scribed above. The mean protein concentrations mea-
sured were 0.39 and 0.19 g/dL (3.9 and 1.9 g/L), 
respectively. A linear increase in total protein was 
obtained with both methods after addition of increas-
ing amounts [0.05-0.75 g/L (0.5-7.5 g/L) bile] of BSA 
or human IgG. However, the fluorometric assay seemed 
to underestimate the amounts of protein added to the 
bile samples, whereas more complete recovery was 
achieved with the Lowry method (Figure 1) used in 
the study. 
Significantly higher concentrations of total protein 
were found in bile samples with crystals [0.80 ± 0.40 
g/dL (8.0 ± 4.0 g/L)] than in samples without crystals 
[0.63 ± 0.26 g/dL (6.3 ± 2.6 g/L)] (P = 0.02) (Table 1). 
In samples containing cholesterol crystals, a trend to 
higher mean concentrations of cholesterol and to a 
higher cholesterol saturation index was observed 
(Table 1), while total lipid, bile acid, phospholipid 
concentrations, and pH values were not significantly 
different in the two groups of bile samples. Figure 2 
shows the relationship between individual values of 
the total lipids and total protein in bile samples with 
and without crystals. Although a large overlap in bile 
samples with and without crystals was observed, high 
protein concentrations were found more frequently in 
samples containing crystals and only rarely in those 
without crystals. Indeed, of 22 samples with total 
protein concentrations >1.0 g/dL (>10.0 g/L), 20 
contained cholesterol crystals and only two contained 
no crystals. No significant correlation between total 
lipids and total protein was found in either of the two 
groups. However, bile acids showed a highly signifi-
cant correlation to phospholipid and cholesterol con-
centrations in samples both with and without choles-
terol crystals (data not shown). Biliary pH was not 
different in the two groups of bile samples (Table 1), 
and no correlation between individual values of pH 
and bile acid concentrations was found (Figure 3). 
Discussion 
Our study demonstrates that total protein con-
centration is significantly higher in bile with choles-
terol crystals than in bile without crystals. This 
finding is in accordance with earlier observations by 
Gallinger et al. (15) and Yu and Guan-Zang (16), who 
found significantly higher protein concentrations in 
bile samples from patients with cholesterol gallstones 
than in samples from patients with pigment stones. 
Table 1. Concentrations of Total Protein, Bile Acids, Phospholipids, Cholesterol, and Total Lipids, Cholesterol Saturation 
Index, and pH in 73 Gallbladder Bile Samples With and 35 Samples Without Cholesterol Crystals 
Samples w i t h Samples w i t h o u t 
cholesterol crystals cholesterol crystals 
Protein; g/dL [g/L] 0.80 0.40 (8.0 ± 4.0) 0.63 0.26 (6.3 ± 2.6)° 
Bile acids; g/dL (mmol/L) 4.02 2.21 (82.1 ± 45.1) 4.49 2.50 (91.5 ± 50.9) 
Phospholipids;g/dL {mmol/L) 2.33 1.24 (30.1 ± 16.0) 2.41 ± 1.65 (31.1 ± 21.4) 
Cholesterol; g/dL (mmol/L) 0.46 ± 0.22 (12.0 ± 5.8) 0.39 ± 0.20 (10.1 ± 5.3) 
Total l ip ids ; g/dL [g/L) 6.8 3.2 (68 ± 32) 7.4 ± 4.1 (74 ± 41) 
Cholesterol saturation index 1.6 0.7 1.4 ± 0.8 
p H 7.71 0.43 7.60 0.44 
aP = 0.02 compared w i t h samples w i t h crystals. 
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Figure 2. Relation of total protein to total lipid concentration in 
[A] 35 bile samples without (r = 0.13) and {B) 73 samples with 
cholesterol crystals (r = 0.19). 
Contrary to these findings, Yamazaki et al. (26) did 
not observe differences in the concentrations of total 
biliary proteins between patients with cholesterol or 
pigment gallstones and subjects without gallstones, 
but a type II error due to the relatively small number 
of stone-free and pigment bile samples cannot be 
excluded. In our study, there was a considerable 
overlap between the total protein concentrations in 
gallbladder bile with crystals from patients with 
cholesterol stones and in bile without cholesterol 
crystals from patients with pigment or mixed stones. 
In accordance with the observations of Yamazaki et 
al. (26), patients with cholesterol gallstones could not 
be separated from those with pigment gallstones on 
the basis of the total protein concentration of gallblad-
der bile. However, in 22 bile samples with protein 
concentrations >1.0 g/dL (>10.0 g/L), cholesterol 
crystals were detected in all but 2 samples. The close 
association of high biliary protein [> 1.0 g/dL (> 10.0 
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Figure 3. Relation of pH to total bile acid concentration in (A) 35 
bile samples without (r = -0 .15) and [B) 73 samples with choles-
terol crystals (r = -0 .02) . 
protein concentration may be an important factor in 
the formation of cholesterol crystals. Our findings are 
supported by a recent study of Strasberg et al. (27) in 
which high protein concentrations were found to be 
associated with reduced metastability of bile in an 
early stage of cholesterol gallstone formation. 
The fluorometrically measured protein concentra-
tions in bile in the study of Gallinger et al. (15) were 
only one third of the protein concentrations measured 
in our study using the Lowry assay. A similar differ-
ence between the two methods was shown in a more 
recent study by Harvey et al. (24). A carefully per-
formed evaluation of several quantitative techniques 
of protein determination was performed by Yamazaki 
et al. (26) in bile samples from subjects with and 
without gallstones. The authors also observed lower 
biliary protein concentrations with the fluorometric 
method than with the Lowry procedure. However, 
despite large quantitative differences an excellent 
correlation of the two methods was obtained. The 
authors concluded that if bile is adequately pretreated 
(e.g., by dialysis or T C A precipitation and delipida-
tion), use of either method will yield comparable 
results. We compared both protein determinations in 
bile using native bile samples that were "spiked" with 
BSA or human IgG in several physiological concentra-
tions. As shown in Figure 1, the added amounts of 
BSA and IgG were correctly measured by the Lowry 
procedure and underestimated by the fluorometric 
assay. It is conceivable that the absorption caused by 
biliary pigment explains partially the higher values 
obtained with the Lowry procedure. On the other 
hand, because it appears that recovery of added 
protein is better at lower concentrations than at 
higher concentrations in the fluorometric assay (Fig-
ure 1), it is also conceivable that not enough fluores-
camine reagent is being added in the assay at higher 
protein concentrations and therefore recovery is lower 
because of insufficient reagent. This would be partic-
ularly true if the samples were not sufficiently diluted 
before the addition of the fluorescamine reagent. In 
our study the final dilution of the bile samples before 
the fluorometric readings was similar to the dilutions 
recommended by Harvey et al. (24). 
The data presented in this study allow only specula-
tion about the origin of the elevated protein concentra-
tion in crystal-containing bile samples. No significant 
correlation between total lipid and total biliary pro-
tein concentrations was found in our study. There-
fore, it is unlikely that the high biliary protein levels 
are merely caused by concentration of bile. In fact, 
even in very dilute bile samples with total lipid 
concentrations as low as 1-5 g/dL (10-50 g/L), high 
biliary protein concentrations were measured (Figure 
2). Elevated protein levels in bile may reflect in-
creased amounts of biliary mucus. A role for biliary 
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mucus in gallstone formation has been demonstrated 
in a number of studies (11,12,28-30). Mucus is a 
complex mixture of glycoproteins, water, electrolytes, 
lipids, serum proteins, and immunoglobulins with 
variable protein contents (15%-30%) (31). Harvey et 
al. (32) described maximal elevations of mucin glyco-
proteins to 0.62 ± 0.41 g/dL (6.2 ± 4.1 g/L) in four 
samples from patients with complete obstruction of 
the cystic duct. Values below 0.1 g/dL (1 g/L) were 
measured in bile samples from patients with function-
ing gallbladders. These data suggest that the maximal 
increase in biliary protein concentrations [> 1.0 g/dL 
(> 10 g/L)] observed in our study cannot be explained 
by alterations in biliary glycoproteins alone. 
Mucosal inflammation of the gallbladder is com-
mon in cholesterol gallstone disease. In the intestinal 
mucosa the cytotoxic activity of activated inflamma-
tory cells causes an increase in mucosal permeability 
with a subsequent leakage of plasma proteins into the 
intestinal lumen (33). Similarly, inflammatory changes 
of the gallbladder mucosa may allow an increased flux 
of plasma proteins into the bile. The high biliary 
protein concentrations observed in our study may 
therefore reflect mucosal inflammation of the gallblad-
der wall, and it is conceivable that high protein 
concentrations in bile are only one aspect of inflamma-
tion-induced changes in bile that together favor cho-
lesterol crystal formation. 
Biliary pH in our study was not significantly dif-
ferent in bile with and without crystals (Table 1). Our 
values are higher than those reported by Magnuson et 
al. (34), who found different mean pH in gallbladder 
bile samples from patients with cholesterol stones 
(pH 7.41), in samples from patients with pigment 
stones (pH 7.36), and in control samples (pH 7.27). 
Because bile samples were maintained in closed 
syringes before analysis, a loss of C 0 2 to the atmo-
sphere cannot explain the more alkaline pH in our 
study. The question of whether defective acidification 
(17) was responsible for our findings could not be 
tested in this study because a control group without 
stones was not available for comparison. 
In conclusion, our results show that besides choles-
terol supersaturation, high total biliary protein concen-
tration may facilitate the formation of cholesterol 
crystals and the subsequent development of choles-
terol stones in bile. Further studies are needed to 
elucidate the origin of the increased protein concentra-
tions in bile and to define the mechanisms by which 
protein-rich bile favors cholesterol crystal formation. 
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